SMTL ID : 4z6i.2 (1 other biounit)

Crystal structure of BRD9 bromodomain in complex with a substituted valerolactam quinolone ligand

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

1 x 4L3: tert-butyl [(2R,3S)-1-(1,4-dimethyl-2-oxo-1,2-dihydroquinolin-7-yl)-6-oxo-2-phenylpiperidin-3-yl]carbamate(Non-covalent)

4L3.1: 11 residues within 4Å: Chain A: H.31, G.32, F.33, F.34, F.36, P.37, V.38, I.42, A.43, N.89, Y.95 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:F.33, A:F.36, A:I.42, A:I.42, A:A.43 Hydrogen bonds: A:G.32, A:N.89 pi-Stacking: A:Y.95, A:Y.95

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Clark, P.G. et al., LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor. Angew.Chem.Int.Ed.Engl. (2015)

Release Date

2015-05-20

Peptides

Bromodomain-containing protein 9: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Bromodomain-containing protein 9

Related Entries With Identical Sequence